Contraceptive Drugs and Devices Market By Product Type (Drugs {Oral Contraceptives, Injectable Contraceptives, Emergency Contraceptives, Topical Contraceptives, Vaginal Contraceptives}, Devices {Intrauterine Devices (IUDs), Implants, Male Condoms, Female Condoms, Diaphragms, Contraceptive Sponges}), By Use Method (Short-term Contraceptives, Long-term Contraceptives), By End-User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1586 | 230 Pages


Report Coverage:

By Product Type

  • Drugs
    • Oral Contraceptives
    • Injectable Contraceptives
    • Emergency Contraceptives
    • Topical Contraceptives
    • Vaginal Contraceptives
  • Devices
    • Intrauterine Devices (IUDs)
    • Implants
    • Male Condoms
    • Female Condoms
    • Diaphragms
    • Contraceptive Sponges

By Use Method

  • Short-term Contraceptives
  • Long-term Contraceptives

By Distribution Channel

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Online Pharmacies

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Johnson & Johnson
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • CooperSurgical, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (Viatris)
  • HLL Lifecare Limited
  • Reckitt Benckiser Group Plc
  • Abbott Laboratories
  • Lupin Pharmaceuticals, Inc.
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Exeltis USA, Inc.
  • Merck Group
  • Amgen Inc.
  • Cadila Healthcare Limited
  • Piramal Healthcare
  • HRA Pharma

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.